Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
Keywords:
Materias Investigacion::Ciencias de la Salud::Oncología
Publisher:
American Society of Clinical Oncology (ASCO)
Note:
Creative Commons Attribution Non-Commercial No Derivatives 4.0 License
Citation:
Naumann, R.W. (R. Wendel); Hollebecque, A. (Antoine); Meyer, T. (Tim); et al. "Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial". Journal of Clinical Oncology. 37 (31), 2019, 2825 - 2834
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.